Acasti Pharma, Inc.
|Number of Estimates|
Acasti Pharma, Inc. engages in the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases. It focuses on the research of prescription drugs using omega-3, fatty acids derived from krill oil. The company was founded by Henri Harland on February 1, 2002 and is headquartered in Laval, Canada.
Market Cap: 48.1 Million
Primary Exchange: NASDAQ
Shares Outstanding: 90.2 Million
Float: 80 Million
Sector: Health Technology
Industry: Pharmaceuticals: Other
Longest drawdown: 1754 trading days
From: 2013-08-05 To: 2020-07-01
|Ex-Date||Payment Date||Record Date||Declared Date||Amount||Flag||Dividend Type||Qualified||Indicated|
|Ex-Date||Declared Date||Record Date||Payment Date||Ratio||To Factor||For Factor|